December 2021 - Dr. Jesse Engreitz was selected as a recipient of the Additional Ventures Single Ventricle Research Fund for his research project "A reference map of enhancers during human fetal heart development to understand the genetic etiology of single ventricle diseases". This work will be performed in collaboration with Dr. William Goodyer (Dept. of Pediatrics - Cardiology) and Dr. William Greenleaf (Genetics Department).
November 2021 - Dr. Mark Skylar-Scott was awarded the Beckman Center for Molecular and Genetic Medicine 2021 Technology Development Grant for his work on the “Development of a photo-enzymatic 3D bioprinter for pediatric tissue engineered vascular grafts”. This project will be performed in collaboration with Dr. Steven Boxer (Dept. of Chemistry) and Dr. Michael Ma (Dept. of Cardiovascular Surgery).
September 2021 - Dr. Jesse Engreitz and Dr. Tom Quertermous were selected to lead a Functional Characterization Center for the inaugural NIH/NHGRI Impact of Genomic Variation on Function (IGVF) consortium. Learn more about consortium efforts here, in a press release by NHGRI.
June 2021 - Engreitz Lab postdoctoral fellow, Dr. Gabriella Martyn, was awarded 2 postdoctoral fellowships for her work on linking variants to their effects on target genes via prime editing mediated mutagenesis. She will be supported by the Stanford School of Medicine Dean’s Postdoctoral Fellowship and the Walter V. and Idun Berry Postdoctoral Scholarship.
June 2021 - BASE Faculty Dr. Mark Skylar-Scott (Dept. of Bioengineering) was selected as a 2021 Baxter Foundation Faculty Scholar for his work on “Laser 3D Printed Human Capillary Models to Study SARS-CoV-2 Entry”. Congrats, Mark!
May 2021 - Two Skylar-Scott Lab graduate students were selected as recipients of the Stanford Bio-X PhD Fellowship. Joshua Sampson, Bioengineering PhD student, will study “Optical Coagulation for 3D Bioprinting In Vitro and Directed Homeostasis In Vivo” (Bio-X co-mentors: Dr. Steven Boxer, Dr. Michael Ma). Jonathan Weiss, Bioengineering PhD student, will work on “Organ-scale Biofabrication: 3D Bioprinting of Engineered Pluripotent Stem Cells to Form a Mature Human Ventricle” (Bio-X co-mentor: Dr. Joe Woo).
April 2021 - Dr. Jesse Engreitz published a study in Nature (read it here) in which he built genome-wide enhancer maps to systematically connect thousands of noncoding disease variants to functions in specific cell types. Using inflammatory bowel disease (IBD) as a testbed, the team accurately predicted which enhancers contain risk variants for IBD and experimentally validated these results by modulating a predicted enhancer in immune cells in vitro. Learn more about the study here, in a story released by the Broad Institute.
March 2021 - Two BASE graduate students were awarded the National Science Foundation Graduate Research Fellowship. Skylar-Scott Lab Bioengineering PhD student Jonathan Weiss will study “Genomic Engineering of Pluripotent Stem Cells to Enable Whole Organ-Scale 3D Bioprinting” and Engreitz Lab Genomics PhD student Michael Montgomery’s project will focus on “Untangling Temporal Dynamics of Enhancer-Gene Interactions In Cardiomyocyte Differentiation”.
January 2021 - Engreitz Lab postdoctoral fellow, Dr. Dulguun Amgalan, was awarded 2 prestigious fellowships for her project “Regulatory maps of endothelial cell differentiation to connect congenital heart disease risk variants to target genes”. Her work will be supported by the American Heart Association + Children’s Heart Foundation Congenital Heart Defect Research Award and the Stanford Maternal and Child Health Research Initiative Postdoctoral Support Award.